Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 112101-75-4
2. 5[(r)-(2-aminopropyl)]-2-methoxybenzenesulfonamide Hydrochloride
3. (r)-(+)-5-(2-aminopropyl)-2-methoxybenzene Sulfonamide Hydrochloride
4. 5-[(2r)-2-aminopropyl]-2-methoxybenzenesulfonamide;hydrochloride
5. (r)-(-)-5-(2-aminopropyl)-2-methoxybenzenesulphonamide Hcl
6. 5-[(2r)-2-aminopropyl]-2-methoxy-benzenesulfonamide Hydrochloride
7. Schembl3939257
8. (r)-(+)-5-(2-aminopropyl)-2-methoxybenzene Sulfonamide
9. Dtxsid40524856
10. (r)-(+)-5-(2-aminopropyl)-2-methoxybenzenesulfonamidehydrochloride
11. 5-[(r)-(2-aminopropyl)]-2-methoxybenzenesulfonamide Hydrochloride
12. Akos015901415
13. Ac-5618
14. Cs-0440941
15. A1-00091
16. J-002705
17. J-002706
18. (r)-5-(2-aminopropyl)-2-methoxybenzenesulfonamidehydrochloride
19. Benzenesulfonamide,5-[(2r)-2-aminopropyl]-2-methoxy-, Hydrochloride (1:1)
20. Benzenesulfonamide,5-[(2r)-2-aminopropyl]-2-methoxy-,hydrochloride(1:1)
21. 5-[(2r)-2-aminopropyl]-2-methoxybenzene-1-sulfonamide--hydrogen Chloride (1/1)
| Molecular Weight | 280.77 g/mol |
|---|---|
| Molecular Formula | C10H17ClN2O3S |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 4 |
| Exact Mass | 280.0648413 g/mol |
| Monoisotopic Mass | 280.0648413 g/mol |
| Topological Polar Surface Area | 104 Ų |
| Heavy Atom Count | 17 |
| Formal Charge | 0 |
| Complexity | 313 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
ABOUT THIS PAGE
A Methoxybenzenesulfonamide Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Methoxybenzenesulfonamide Hydrochloride, including repackagers and relabelers. The FDA regulates Methoxybenzenesulfonamide Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Methoxybenzenesulfonamide Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Methoxybenzenesulfonamide Hydrochloride supplier is an individual or a company that provides Methoxybenzenesulfonamide Hydrochloride active pharmaceutical ingredient (API) or Methoxybenzenesulfonamide Hydrochloride finished formulations upon request. The Methoxybenzenesulfonamide Hydrochloride suppliers may include Methoxybenzenesulfonamide Hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Methoxybenzenesulfonamide Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Methoxybenzenesulfonamide Hydrochloride Drug Master File in Japan (Methoxybenzenesulfonamide Hydrochloride JDMF) empowers Methoxybenzenesulfonamide Hydrochloride API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Methoxybenzenesulfonamide Hydrochloride JDMF during the approval evaluation for pharmaceutical products. At the time of Methoxybenzenesulfonamide Hydrochloride JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Methoxybenzenesulfonamide Hydrochloride suppliers with JDMF on PharmaCompass.
Methoxybenzenesulfonamide Hydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Methoxybenzenesulfonamide Hydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Methoxybenzenesulfonamide Hydrochloride GMP manufacturer or Methoxybenzenesulfonamide Hydrochloride GMP API supplier for your needs.
A Methoxybenzenesulfonamide Hydrochloride CoA (Certificate of Analysis) is a formal document that attests to Methoxybenzenesulfonamide Hydrochloride's compliance with Methoxybenzenesulfonamide Hydrochloride specifications and serves as a tool for batch-level quality control.
Methoxybenzenesulfonamide Hydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Methoxybenzenesulfonamide Hydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Methoxybenzenesulfonamide Hydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Methoxybenzenesulfonamide Hydrochloride EP), Methoxybenzenesulfonamide Hydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Methoxybenzenesulfonamide Hydrochloride USP).
LOOKING FOR A SUPPLIER?
